International Journal of Drug Regulatory Affairs

  • Year: 2020
  • Volume: 8
  • Issue: 3

Prevention, treatment and cure for COVID-19

  • Author:
  • Jitendra Kumar Badjatya1, Pooja Vinod Chaudhari2,, Aesha Bheda3
  • Total Page Count: 20
  • Page Number: 36 to 55

1Regulatory Affairs Professional & Editor-In-Chief, IJDRA Journal, Delhi, India

2Regulatory Affairs Professional, Nandan Villa, Near Patidar Bhavan, Vaidya Nagar, Nashik, India

3Regulatory Affairs Executive, Macheal Laboratories, Ahmedabad, India

*Corresponding author Tel.: +91-9099564088, E-mail address: pchaudhari1996@gmail.com (Pooja Vinod Chaudhari)

Online published on 24 May, 2021.

Abstract

Few months ago, COVID-19 was totally foreign to all but now it has spread its route in India. Starting from one case, the virus has spread in every corner of India. Coronavirus disease 2019 is an infection cause by Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2). The infection expresses as mild flu to severe acute respiratory infection. World health Organization (WHO) declared COVID-19 as a global pandemic disease. Even with the implementation of strong international travel restriction, by a large number of individuals exposed to SARS-CoV-2 has resulted in the spread of virus worldwide. At global level, scientific communities including various healthcare professionals are working to understand the virological, epidemiological and clinic aspects of COVID-19 in order to identify effective drugs and vaccines. Ministry of Health and Family Welfare, Government of India and Indian Council of Medical Research (ICMR) has formulated several guidelines, advisory for social distancing, diagnosis and management of the disease.

Keywords

COVID-19, Coronavirus, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), Arsenicum Album, Ayush Kadha Immunity Booster, Sputnik-V, COVAXIN, Coronil, Convalescent Plasma Therapy, Nucleic Acid Amplification Test (NAAT)